Professor Dr. Abdu Adem received his Ph.D from Uppsala University (Sweden) in Pharmacology in 1987. Following a postdoctoral training at the Institute Pasteur (Paris, France), CNRS (France) and Karolinska Institute (Stockholm, Sweden) Prof. Adem accepted a postdoctoral position at the Karolinska Institute, Sweden. In 1991, while still at the Karolinska Institute, he received his Docent title (Habilitation). In 1999 he was recruited from the Karolinska Institute to join the College of Medicine and Health Sciences at United Arab Emirates University in Al Ain as a full Professor. In 2020 Prof. Adem was recruited by the College of Medicine at Khalifa University. In the last 20 years in the UAE Prof. Adem has made significant contributions in the areas of Research, Teaching and Service.
Most research interests for a scientist
Prof. Adem’s long-term goal has been to develop a vigorous functional neuroscience research, education, and training program. The main focus of his research has been neurodegeneration and neurodegenerative disorders like Alzheimer's disease.
Another aspect of his research has been towards understanding the biology of diabetes and its complications especially in the light that 24-28% of the United Arab Emirates population suffers from diabetes.
Prof. Adem has published over 230 manuscripts (H-index of 45, i10 index 155 and 6641 citations; google Scholar). Most of his work is published in top ranking journals of his field. Prof. Adem and his team have patented two groups of novel anti-cancer compounds and two new anti-diabetic compounds as potential new drugs and has three new pending patents.
Neurodegenerative Diseases and Diabetes